Back to AVTX
GOLDMAN SACHS GROUP INC → AVTX
GOLDMAN SACHS GROUP INC AVTX Position History
Avalo Therapeutics, Inc. • Healthcare
Quarters held
2
Latest value
$570K
Q2 2026
Peak value
$16.9M
First seen
Q2 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2026 | $16.9M |
| Q2 2026 | $570K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $570K | 30.9K | — | — |
| Q2 2026 | $16.9M | 915.5K | — | — |